Preferred Label : Durvalumab/Tremelimumab Regimen;

NCIt synonyms : Imfinzi/Imjudo Regimen; Tremelimumab/Durvalumab; Tremelimumab/Durvalumab Regimen; Durvalumab/Tremelimumab; Durvalumab/Tremelimumab-actl Regimen; Imjudo/Imfinzi;

NCIt related terms : Durvalumab and Tremelimumab;

NCIt definition : A regimen consisting of durvalumab and tremelimumab that may be used in the treatment of esophageal and esophagogastric junction, hepatocellular, and gastric cancer.;

NCI Metathesaurus CUI : CL1904893;

Codes from synonyms : 7161;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3448228/fr/imjudo-/-imfinzi-tremelimumab-/-durvalumab-carcinome-hepato-cellulaire-chc
2023
false
false
false
France
antineoplastic combined chemotherapy protocols
Durvalumab/Tremelimumab Regimen
insurance, health, reimbursement
treatment outcome
infusions, intravenous
adult
Advanced Adult Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
Child-Pugh Class A
ECOG Performance Status 0
ECOG Performance Status 1
evaluation of the transparency committee
carcinoma, hepatocellular
durvalumab
tremelimumab

---
Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.